The latest biotechnology news | Bio News
psoriasis awareness

Psoriasis awareness: The condition is more than skin deep

Over 8 million people in the U.S., and 125 million worldwide, live with ...
Read More
biotech M&A

BIO 2025: As M&A slows, biotechs need to show good data

M&A in biotech has slowed from its peak in 2023 but there are ...
Read More
IMG_8023

BIO 2025: How weight loss drugs are disrupting chronic disease

“Initial weight loss is just the first chapter,” said Mia de Graaf, Deputy ...
Read More
IMG_7847

BIO 2025: Psychedelics go mainstream – what’s next?

When experts discussed clinical uses of psychedelics two years ago at the 2023 ...
Read More
CRB1

Mother inspired to support solutions for her boys’ blindness

For most of her life, the only things coming out of left field ...
Read More
gene therapy redosing

BIO experts discuss challenges and offer opportunities for developing redosable gene therapies

As drug makers work to develop safe, effective gene therapies, their progress can ...
Read More
Save with Avantor and BIO Business Solutions

EDITORS' CHOICE

Fritz Bittenbender

A conversation with Fritz Bittenbender, new BIO Board Chair

The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More

LATEST NEWS

Federal Policy

Psoriasis awareness: The condition is more than skin deep

Over 8 million people in the U.S., and 125 million worldwide, live with psoriasis—about 2–3% of the population. Far from being a simple cosmetic condition, ...
Health

BIO 2025: As M&A slows, biotechs need to show good data

M&A in biotech has slowed from its peak in 2023 but there are still deals to be done, especially for companies who can present good ...
BIO Events

BIO 2025: How weight loss drugs are disrupting chronic disease

“Initial weight loss is just the first chapter,” said Mia de Graaf, Deputy Executive Health Editor at Business Insider, “but the real challenge and opportunity ...
BIO Events

BIO 2025: Psychedelics go mainstream – what’s next?

When experts discussed clinical uses of psychedelics two years ago at the 2023 Biotechnology Innovation Organization (BIO) International Convention, there was some interest in separating ...
Health

Mother inspired to support solutions for her boys’ blindness

For most of her life, the only things coming out of left field for Kristin Smedley were fly balls, but with the birth of her ...

Welcome, John F. Crowley!

Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.

Federal Policy

State Policy

International

Bio's View

Scroll to Top